Total Return chart Novartis AG

Equities

NOVN

CH0012005267

Pharmaceuticals

Market Closed - Swiss Exchange Other stock markets 10:01:52 16/01/2026 pm IST			5-day change	1st Jan Change
115.60 ^CHF	+0.98%		+1.37%	+5.47%

16/01	Novartis Ianalumab Receives Fda Breakthrough Therapy Designation for Sjogren's Disease	CI
16/01	Novartis Receives US FDA Breakthrough Therapy Designation for Ianalumab to Treat Sjogren's Disease	MT

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.

Past dividends on Novartis AG

11/03/2025	Annual 3.5 CHF
07/03/2024	Annual 3.3 CHF
09/03/2023	Annual 3.2 CHF
08/03/2022	Annual 3.1 CHF
04/03/2021	Annual 3 CHF
03/03/2020	Annual 2.95 CHF
04/03/2019	Annual 2.85 CHF
06/03/2018	Annual 2.8 CHF
02/03/2017	Annual 2.75 CHF
25/02/2016	Annual 2.7 CHF
03/03/2015	2.6 CHF
27/02/2014	Annual 2.45 CHF
26/02/2013	Annual 2.3 CHF
27/02/2012	Annual 2.25 CHF
24/02/2011	Annual 2.2 CHF
02/03/2010	Annual 2.1 CHF
27/02/2009	Annual 2 CHF
29/02/2008	Annual 1.6 CHF
09/03/2007	Annual 1.35 CHF
03/03/2006	Annual 1.15 CHF
04/03/2005	Annual 1.05 CHF
27/02/2004	Annual 1 CHF
07/03/2003	Annual 0.95 CHF
26/03/2002	Annual 0.9 CHF
27/03/2001	Annual 34 CHF
17/04/2000	Annual 32 CHF
26/04/1999	Annual 29 CHF
24/04/1998	Annual 25 CHF
25/04/1997	Annual 20 CHF

Rankings

Rankings

Currency / Forex

Currencies & Forex

Commodities

Cryptocurrencies

Cryptocurrencies

Interest Rates

Interest Rates Area

As early as today, start finding the best investment opportunities!